Skip to content

Effects of Training Based on the Pilates Method on the Blood Pressure of Hypertensive Women

Blood Pressure, Autonomic Heart Rate Modulation, Cardiorespiratory Parameters, Functionality and Quality of Life in Hypertensive Women After 16 Weeks of Training Based on the Pilates Method

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03791307
Enrollment
60
Registered
2019-01-02
Start date
2019-04-08
Completion date
2019-12-20
Last updated
2020-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

Pilates method, Blood pressure, Autonomic heart rate modulation

Brief summary

The main objective of this study is to evaluate and compare the effect of the Pilates method associated with aerobic exercise and the traditional Pilates method on the blood pressure of hypertensive medicated women. In addition, we aim to analyze and compare the chronic effects of training on cardiac autonomic modulation, on cardiorespiratory fitness, functionality and quality of life.

Detailed description

Subjects will be allocated randomly in three groups: (1) Traditional Pilates group, which will perform only exercises based on the traditional Pilates method, (2) Modified Pilates group, which will perform exercises based on the Pilates method alternated with active rest periods on treadmill ergometer, (3) Control group: will not perform any physical exercise during the trial period. The sessions will be performed two times a week, during 16 weeks. Subjects will be evaluated before and after 16 weeks of intervention.

Interventions

OTHERTraditional Pilates group

The participants will perform only exercises based on the traditional Pilates method, 2 times a week, for 50 minutes, for 16 weeks.

OTHERModified Pilates group

The participants will perform exercises based on the Pilates method alternated with active rest periods on treadmill ergometer, 2 times a week, for 50 minutes, for 16 weeks.

Sponsors

Catholic University of Brasília
CollaboratorOTHER
João Luiz Q. Durigan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

One researcher will be blinded to the conduct of evaluations and revaluations. One researcher will be blinded for outcomes statistics analysis.

Eligibility

Sex/Gender
FEMALE
Age
30 Years to 59 Years
Healthy volunteers
No

Inclusion criteria

* Hypertensive women * Age 30 to 59 * Sedentary or who do not practice any form of physical exercise regularly for at least 6 months * Make use of antihypertensive medication * Who have medical clearance for physical exercise

Exclusion criteria

* Complaint of pain that influences or makes the performance of the tests / exercises proposed impossible * Congenital or acquired anomalies of upper limbs and lower limbs * Presence of musculoskeletal disease or injury that interfere the performance of exercises * Changes in pharmacological treatment during the experimental period * Release for physical activity suspended during intervention * Absence in more than 25% of the exercise sessions

Design outcomes

Primary

MeasureTime frameDescription
Ambulatory blood pressureChange from Baseline systolic and diastolic Blood Pressure at 16 weeksSystolic and diastolic blood pressure will be measured by 24-hour Ambulatorial Monitoring Blood Pressure, before and after trial period.

Secondary

MeasureTime frameDescription
Clinical heart rateChange from Baseline clinical heart rate at 16 weeksClinical assessment of heart rate will be measured by a heart rate monitor after 10 minutes of rest, before and after trial period.
Autonomic heart rate modulationChange from Baseline autonomic heart rate modulation at 16 weeksAutonomic heart rate modulation will be assessed by the heart rate variability method using a heart rate monitor, before and after trial period.
Ventilatory threshold measured by the cardiopulmonary exercise testChange from baseline and at 16 weeksThe ventilatory threshold will be measured by the cardiopulmonary exercise test. An ergospirometric exercise test will be performed, consisting of increasing loads, with no pauses between the stages until exhaustion of the volunteer. The examination will be performed in a treadmill with ergospirometric and electrocardiographic analysis.
Analysis of the quality of lifeChange from Baseline quality of life at 16 weeksQuality of life will be analyzed by means of the questionnaire World Health Organization Quality Of Life/Bref (WHOQOL/bref). The questionnaire has twenty-six questions that involve different aspects of daily life and deal with four domains of quality of life: physical, psychological, environmental and social relations. The response is represented by scores ranging from one to five, with the worst score being one and the best score being five. The results of the domains have values between zero and one hundred, with the worst being the closest to zero and the best the closest to one hundred, thus, a value equal to 50 for a given domain can be considered median for that domain.
FlexibilityChange from Baseline flexibility at 16 weeksFlexibility will be analyzed by bank of wells test, before and after trial period.
StrengthChange from Baseline strength at 16 weeksStrength will be analyzed by hydraulic handgrip dynamometer, before and after trial period.
Clinical blood pressureChange from Baseline systolic and diastolic Blood Pressure at 16 weeksClinical assessment of systolic and diastolic blood pressure will be measured by an automatic arm blood pressure monitor after 10 minutes of rest, before and after trial period.
Speed to lift from a layered positionChange from Baseline speed at 16 weeksSpeed to lift from a layered position will be evaluated by a stopwatch, before and after trial period
Speed to put on and tie his shoesChange from Baseline speed at 16 weeksSpeed to put on and tie his shoes will be evaluated by a stopwatch, before and after trial period.
Body weightChange from Baseline body weight at 16 weeksBody weight will be measured using a digital scale, before and after trial period.
HeightChange from Baseline at 16 weeksHeight will be measured using a stadiometer.
Body Mass IndexChange from Baseline body mass index at 16 weeksWill be analyzed as weight divided by height squared.
Circumference measurementsChange from Baseline circumference measurements at 16 weeksWill be analyzed the circumference of hip, waist, neck, abdomen, before and after trial period.
Speed to lift from a sitting positionChange from Baseline speed at16 weeksSpeed to lift from a sitting position will be evaluated by a stopwatch, before and after trial period.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026